Antiviral flu vaccines may soon become a U.S. shortage issue
Antiviral peptide tablets, a curative product that treats common (and sometimes deadly) flu-like symptoms, are scheduled to be launched in the U.S. as early as next month. Can the FDA’s supervision of antiviral study…